HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]

HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]

For Immediate Release: August 15, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the […]

Product: Dietary SupplementsDrugs Recipient: Heavenly Natural Products 100 Monroe St #406Centerton, AR 72719United States Issuing Office: Center for Food Safety and Applied Nutrition (CFSAN) United States […]

Product: Drugs Issuing Office: Center for Drug Evaluation and Research | CDER United States Date:               December 7, 2020 RE:      Unapproved and Misbranded Products Related to […]

Product: Drugs Recipient: Rat’s Army 4126 US HWY 93 SKalispell, MT 59901United States [email protected] Issuing Office: Center for Drug Evaluation and Research | CDER United States […]

Product: DrugsMedical Devices Issuing Office: Center for Devices and Radiological Health United States WARNING LETTER Date:     November 30, 2020 TO: 605 Louis Dr Ste 502Warminster, […]

On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System) containing melphalan (HEPZATO, Delcath Systems, Inc.) as a liver-directed […]

Delivery Method: Via Email Product: Drugs Issuing Office: Office of Unapproved Drugs and Labeling Compliance United States WARNING LETTER August 9, 2023 RE: 663727 Dear Micah […]